PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10319729-5	1999	Inhibition of the MAPK pathway by use of the specific MEK1/2 inhibitor (10 microM PD98059) in both HL60/pCEP4 and HL60/Bcl-2 cells prior to irradiation permitted a similar prolonged radiation-induced activation of JNK1.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	82-89	mitogen-activated protein kinase kinase 1	Homo sapiens	54-60	
10319729-5	1999	Inhibition of the MAPK pathway by use of the specific MEK1/2 inhibitor (10 microM PD98059) in both HL60/pCEP4 and HL60/Bcl-2 cells prior to irradiation permitted a similar prolonged radiation-induced activation of JNK1.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	82-89	BCL2 apoptosis regulator	Homo sapiens	119-124	
10319729-5	1999	Inhibition of the MAPK pathway by use of the specific MEK1/2 inhibitor (10 microM PD98059) in both HL60/pCEP4 and HL60/Bcl-2 cells prior to irradiation permitted a similar prolonged radiation-induced activation of JNK1.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	82-89	mitogen-activated protein kinase 8	Homo sapiens	214-218	
10319729-7	1999	Reduced proliferation after combined irradiation and PD98059 treatment in both cell types correlated with reduced Cdc2 activity and arrest in G2/M phase of the cell cycle.	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	53-60	cyclin dependent kinase 1	Homo sapiens	114-118